Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2012 Feb 14;129(6):1666–1668. doi: 10.1016/j.jaci.2011.12.1003

Figure 2.

Figure 2

NK cell cytotoxicity. (A) NK cell cytotoxicity in resting PBMCs was assessed against K562 cells. Dashed lines (B, C) represent short-term IL-2 stimulation in vitro. ADCC was determined by the in vitro addition of Rituximab and is represented by dotted lines (D).